Could immunotherapy spare some colon cancer patients from surgery?
Disease control
Not yet recruiting
This study tests giving an immunotherapy drug (pembrolizumab) before surgery to people with a specific type of colon cancer (dMMR). The goal is to see if the drug can shrink or eliminate the tumor so some patients may avoid surgery and instead be closely monitored. About 152 adul…
Phase: PHASE2 • Sponsor: Ismail Gögenur • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC